Formoterol
- Generic Name
- Formoterol
- Brand Names
- Bevespi, Breyna, Breztri, Duaklir, Duaklir Genuair, Dulera, Foradil, Oxeze, Perforomist, Symbicort, Zenhale
- Drug Type
- Small Molecule
- Chemical Formula
- C19H24N2O4
- CAS Number
- 73573-87-2
- Unique Ingredient Identifier
- 5ZZ84GCW8B
- Background
Formoterol is an inhaled beta-agonist used in the management of COPD and asthma that was first approved for use in the United States in 2001. It acts on bronchial smooth muscle to dilate and relax airways, and is administered as a racemic mixture of its active (R;R)- and inactive (S;S)-enantiomers. A major clinical advantage of formoterol over other inhaled ...
- Indication
Formoterol is indicated in various formulations for the treatment of asthma and COPD. For the treatment of COPD, formoterol is available as a single-entity inhalation solution, in combination with the long-acting muscarinic antagonists (LAMAs) aclidinium and glycopyrronium, and in combination with the corticosteroid budesonide. For the treatment of asthma, f...
- Associated Conditions
- Asthma, Bronchial Asthma, Bronchoconstriction, Chronic Obstructive Pulmonary Disease (COPD), Exercise-Induced Bronchospasm, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
- Associated Therapies
- Maintenance therapy
Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination Treatment
- Conditions
- Interventions
- First Posted Date
- 2016-12-09
- Last Posted Date
- 2020-06-16
- Lead Sponsor
- Neutec Ar-Ge San ve Tic A.Ş
- Target Recruit Count
- 84
- Registration Number
- NCT02988869
- Locations
- 🇹🇷
Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey
A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal Block
- Conditions
- Interventions
- First Posted Date
- 2016-08-01
- Last Posted Date
- 2016-08-01
- Lead Sponsor
- Intech Biopharm Ltd.
- Target Recruit Count
- 99
- Registration Number
- NCT02850484
Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis
- First Posted Date
- 2015-09-10
- Last Posted Date
- 2019-08-01
- Lead Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Target Recruit Count
- 90
- Registration Number
- NCT02546297
- Locations
- 🇨🇳
Shanghai Pulmonary Hospital, Shanghai, Shanghai, China
Small Airways Evaluation and Treatment
- Conditions
- Interventions
- First Posted Date
- 2015-08-18
- Last Posted Date
- 2015-08-18
- Lead Sponsor
- Zhujiang Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT02526758
- Locations
- 🇨🇳
Zhujiang Hospital, Guangzhou, Guangdong, China
A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers
- First Posted Date
- 2015-03-31
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- Mundipharma Research Limited
- Target Recruit Count
- 125
- Registration Number
- NCT02403713
COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers
- First Posted Date
- 2014-11-14
- Last Posted Date
- 2019-03-19
- Target Recruit Count
- 7
- Registration Number
- NCT02291016
- Locations
- 🇺🇸
University of Tennessee Medical Center, Knoxville, Tennessee, United States
Efficacy and Safety of Free Combination of Tiotropium + Formoterol Compared to Formoterol and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Conditions
- Interventions
- First Posted Date
- 2014-09-12
- Last Posted Date
- 2014-09-12
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 74
- Registration Number
- NCT02238119
Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease
- Conditions
- Interventions
- First Posted Date
- 2014-06-06
- Last Posted Date
- 2017-11-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2026
- Registration Number
- NCT02157935
- Locations
- 🇪🇸
Research Site, Zaragoza, Spain
Improving Asthma Control in the Real World: A Systematic Approach to Improving Dulera Adherence
- First Posted Date
- 2014-01-27
- Last Posted Date
- 2018-06-20
- Lead Sponsor
- Asthma Management Systems
- Target Recruit Count
- 50
- Registration Number
- NCT02045875
- Locations
- 🇺🇸
West Penn Allegheny Health System, Pittsburgh, Pennsylvania, United States
A Study to Show That Flutiform is Well Tolerated and Effective in the Treatment of COPD
- Conditions
- Interventions
- First Posted Date
- 2013-09-19
- Last Posted Date
- 2018-10-24
- Lead Sponsor
- Mundipharma Research Limited
- Target Recruit Count
- 1767
- Registration Number
- NCT01946620
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.